Literature DB >> 15679121

The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair follicles.

Sascha Hagemann1, Thomas Günther, Julia Dennemärker, Tobias Lohmüller, Dieter Brömme, Roland Schüle, Christoph Peters, Thomas Reinheckel.   

Abstract

Mice lacking the ubiquitously expressed lysosomal cysteine protease cathepsin L, show a complex skin phenotype consisting of periodic hair loss and epidermal hyperplasia with hyperproliferation of basal epidermal keratinocytes, acanthosis and hyperkeratosis. The recently identified human cathepsin L-like enzyme cathepsin V, which is also termed cathepsin L2, is specifically expressed in cornea, testis, thymus, and epidermis. To date, in mice no cathepsin V orthologue with this typical expression pattern has been identified. Since cathepsin V has about 75% protein sequence identity to murine cathepsin L, we hypothesized that transgenic, keratinocyte-specific expression of cathepsin V in cathepsin L knockout mice might rescue the skin and hair phenotype. Thus, we generated a transgenic mouse line expressing cathepsin V under the control of the human keratin 14 promoter, which mimics the genuine cathepsin V expression pattern in human skin, by directing it to basal epidermal keratinocytes and the outer root sheath of hair follicles. Subsequently, transgenic mice were crossed with congenic cathepsin L knockout animals. The resulting mice show normalization of epidermal proliferation and normal epidermal thickness as well as rescue of the hair phenotype. These findings provide evidence for keratinocyte-specific pivotal functions of cathepsin L-like proteolytic activities in maintenance of epidermis and hair follicles and suggest, that cathepsin V may perform similar functions in human skin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15679121     DOI: 10.1078/0171-9335-00404

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  10 in total

Review 1.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

2.  Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L.

Authors:  Parag P Shah; Michael C Myers; Mary Pat Beavers; Jeremy E Purvis; Huiyan Jing; Heather J Grieser; Elizabeth R Sharlow; Andrew D Napper; Donna M Huryn; Barry S Cooperman; Amos B Smith; Scott L Diamond
Journal:  Mol Pharmacol       Date:  2008-04-10       Impact factor: 4.436

3.  Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters.

Authors:  Lydiane Funkelstein; W Douglas Lu; Britta Koch; Charles Mosier; Thomas Toneff; Laurent Taupenot; Daniel T O'Connor; Thomas Reinheckel; Christoph Peters; Vivian Hook
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

4.  Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.

Authors:  J Dennemärker; T Lohmüller; J Mayerle; M Tacke; M M Lerch; L M Coussens; C Peters; T Reinheckel
Journal:  Oncogene       Date:  2009-12-21       Impact factor: 9.867

Review 5.  Diversity of Neuropeptide Cell-Cell Signaling Molecules Generated by Proteolytic Processing Revealed by Neuropeptidomics Mass Spectrometry.

Authors:  Vivian Hook; Christopher B Lietz; Sonia Podvin; Tomas Cajka; Oliver Fiehn
Journal:  J Am Soc Mass Spectrom       Date:  2018-04-17       Impact factor: 3.109

6.  Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment.

Authors:  Uta Schurigt; Rene Eilenstein; Mieczyslaw Gajda; Carola Leipner; Lisa Sevenich; Thomas Reinheckel; Christoph Peters; Bernd Wiederanders; Rolf Bräuer
Journal:  Inflamm Res       Date:  2012-06-07       Impact factor: 4.575

7.  Characterization of proteolytic activities during intestinal regeneration of the sea cucumber, Holothuria glaberrima.

Authors:  Consuelo Pasten; Rey Rosa; Stephanie Ortiz; Sebastián González; José E García-Arrarás
Journal:  Int J Dev Biol       Date:  2012       Impact factor: 2.203

8.  The HIV Protease Inhibitor Saquinavir Inhibits HMGB1-Driven Inflammation by Targeting the Interaction of Cathepsin V with TLR4/MyD88.

Authors:  John P Pribis; Yousef Al-Abed; Huan Yang; Domokos Gero; Hongbo Xu; Marcelo F Montenegro; Eileen M Bauer; Sodam Kim; Sangeeta S Chavan; Changchun Cai; Tunliang Li; Petra Szoleczky; Csaba Szabo; Kevin J Tracey; Timothy R Billiar
Journal:  Mol Med       Date:  2015-09-02       Impact factor: 6.354

9.  Gene targeting of the cysteine peptidase cathepsin H impairs lung surfactant in mice.

Authors:  Frank Bühling; Martin Kouadio; Caroline E Chwieralski; Ursula Kern; Jens M Hohlfeld; Nicole Klemm; Nicole Friedrichs; Wera Roth; Jan M Deussing; Christoph Peters; Thomas Reinheckel
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

10.  CTSV (cathepsin V) promotes bladder cancer progression by increasing NF-κB activity.

Authors:  Yue Xia; Minghuan Ge; Ling Xia; Guang Shan; Huijun Qian
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.